80 results
424B5
PROK
ProKidney Corp.
13 Jun 24
Prospectus supplement for primary offering
7:00am
price of our Class A ordinary shares on the Nasdaq Capital Market was $2.42 per share.
Tolerantia LLC (“Tolerantia”) effectively controls a majority … , as Chairperson of the Board, is affiliated with and majority owns and controls Tolerantia. As a result, we will continue to be a “controlled company” as defined
424B5
PROK
ProKidney Corp.
10 Jun 24
Prospectus supplement for primary offering
5:13pm
”) effectively controls a majority of the voting power of ProKidney Corp. with respect to the election, appointment or removal of any director. Additionally … , Pablo Legorreta, as Chairperson of the Board, is affiliated with and majority owns and controls Tolerantia. As a result, we will continue
424B5
rozpn87
19 Jan 24
Prospectus supplement for primary offering
4:16pm
S-3
EX-4.1
phmokn5mwu7c9ouat
22 Nov 23
Shelf registration
9:22am
S-3
EX-4.2
z4j1vvlrh
22 Nov 23
Shelf registration
9:22am
S-3
yuxjjo tm2ql00sfix
22 Nov 23
Shelf registration
9:22am
424B3
4kn707l
22 Aug 23
Prospectus supplement
7:13pm
POS AM
za873hfcts6e a6xen6
18 Aug 23
Prospectus update (post-effective amendment)
4:07pm
424B3
5dhps8zj5z11wiktrls0
11 Aug 23
Prospectus supplement
9:09am
DEF 14A
3xfx9tps
26 May 23
Definitive proxy
8:00am
424B3
3x4n0sce
26 May 23
Prospectus supplement
7:32am